awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35669134-06C1C63B-F539-4042-A655-40FD9E942495
Q35669134-06C1C63B-F539-4042-A655-40FD9E942495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35669134-06C1C63B-F539-4042-A655-40FD9E942495
Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin
P2860
Q35669134-06C1C63B-F539-4042-A655-40FD9E942495
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35669134-06C1C63B-F539-4042-A655-40FD9E942495
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
179f6e99c06c4e55c59c2579fac6adf7f2d14531
P2860
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t